Jefferies Financial Group downgraded shares of Option Care Health (NASDAQ:OPCH – Free Report) from a buy rating to a hold rating in a report issued on Thursday morning, Marketbeat Ratings reports. They currently have $26.00 price objective on the stock, down from their previous price objective of $38.00.
Several other brokerages also recently weighed in on OPCH. Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their target price for the company from $43.00 to $29.00 in a research note on Wednesday, October 30th. JMP Securities boosted their target price on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. Finally, Barrington Research reissued an “outperform” rating and issued a $40.00 target price on shares of Option Care Health in a research note on Wednesday, October 23rd. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $31.60.
Get Our Latest Stock Report on Option Care Health
Option Care Health Trading Up 4.6 %
Insider Buying and Selling at Option Care Health
In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now owns 21,339 shares of the company’s stock, valued at $663,429.51. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is owned by company insiders.
Institutional Trading of Option Care Health
A number of institutional investors have recently modified their holdings of the company. State of Michigan Retirement System lifted its position in Option Care Health by 2.4% during the 1st quarter. State of Michigan Retirement System now owns 43,459 shares of the company’s stock worth $1,458,000 after acquiring an additional 1,000 shares in the last quarter. Norden Group LLC lifted its position in Option Care Health by 1,043.1% during the 1st quarter. Norden Group LLC now owns 121,592 shares of the company’s stock worth $4,078,000 after acquiring an additional 110,955 shares in the last quarter. Diversify Advisory Services LLC acquired a new position in Option Care Health during the 1st quarter worth approximately $307,000. FORA Capital LLC lifted its position in Option Care Health by 109.7% during the 1st quarter. FORA Capital LLC now owns 23,011 shares of the company’s stock worth $772,000 after acquiring an additional 12,037 shares in the last quarter. Finally, GSA Capital Partners LLP acquired a new position in Option Care Health during the 1st quarter worth approximately $464,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.
Option Care Health Company Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Stories
- Five stocks we like better than Option Care Health
- Dividend Capture Strategy: What You Need to Know
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- What is the Nikkei 225 index?
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- Trading Halts Explained
- Battle of the Retailers: Who Comes Out on Top?
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.